EP1904081A4 - Compositions and methods to control angiogenesis with cupredoxins - Google Patents

Compositions and methods to control angiogenesis with cupredoxins

Info

Publication number
EP1904081A4
EP1904081A4 EP06787787A EP06787787A EP1904081A4 EP 1904081 A4 EP1904081 A4 EP 1904081A4 EP 06787787 A EP06787787 A EP 06787787A EP 06787787 A EP06787787 A EP 06787787A EP 1904081 A4 EP1904081 A4 EP 1904081A4
Authority
EP
European Patent Office
Prior art keywords
cupredoxins
compositions
methods
control angiogenesis
angiogenesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06787787A
Other languages
German (de)
French (fr)
Other versions
EP1904081A2 (en
Inventor
Rajeshwari Mehta
Brad Taylor
Tohru Yamada
Craig Beattie
Tapas Das Gupta
Ananda Chakrabarty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Illinois
Original Assignee
University of Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/244,105 external-priority patent/US7691383B2/en
Priority claimed from US11/436,592 external-priority patent/US7381701B2/en
Application filed by University of Illinois filed Critical University of Illinois
Publication of EP1904081A2 publication Critical patent/EP1904081A2/en
Publication of EP1904081A4 publication Critical patent/EP1904081A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
EP06787787A 2005-07-19 2006-07-19 Compositions and methods to control angiogenesis with cupredoxins Withdrawn EP1904081A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US70029705P 2005-07-19 2005-07-19
US11/244,105 US7691383B2 (en) 2004-10-07 2005-10-06 Cupredoxin derived transport agents and methods of use thereof
US76474906P 2006-02-03 2006-02-03
US11/436,592 US7381701B2 (en) 2001-02-15 2006-05-19 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
PCT/US2006/027940 WO2007024368A2 (en) 2005-07-19 2006-07-19 Compositions and methods to control angiogenesis with cupredoxins

Publications (2)

Publication Number Publication Date
EP1904081A2 EP1904081A2 (en) 2008-04-02
EP1904081A4 true EP1904081A4 (en) 2008-12-03

Family

ID=37772089

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06787787A Withdrawn EP1904081A4 (en) 2005-07-19 2006-07-19 Compositions and methods to control angiogenesis with cupredoxins

Country Status (10)

Country Link
EP (1) EP1904081A4 (en)
JP (1) JP2009502797A (en)
KR (1) KR20080034905A (en)
AU (1) AU2006284490A1 (en)
BR (1) BRPI0615555A2 (en)
CA (1) CA2615560A1 (en)
IL (1) IL188691A0 (en)
MX (1) MX2008000993A (en)
NO (1) NO20080829L (en)
WO (1) WO2007024368A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8158574B2 (en) * 2004-10-07 2012-04-17 Cdg Therapeutics, Inc. Compositions and methods to prevent cancer with cupredoxins
BRPI0714987A2 (en) * 2006-09-14 2013-07-30 Trutees Of The University Of Illinoi Board Of cupredoxin cancer prevention compositions and methods
AU2007329375A1 (en) 2006-12-04 2008-06-12 The Board Of Trustees Of The University Of Illinois Compositions and methods to treat cancer with cupredoxins and CpG rich DNA

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005018662A1 (en) * 2003-08-15 2005-03-03 Board Of Trustees Of The University Of Illinois Use of polypeptides of the cupredoxin family in cancer therapy
WO2006088508A2 (en) * 2004-10-07 2006-08-24 Ananda Chakrabarty Cupredoxin derived transport agents and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2608398A1 (en) * 2005-05-20 2006-11-30 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating hiv infection with cupredoxin and cytochrome c
CA2607739A1 (en) * 2005-05-20 2006-11-30 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating malaria with cupredoxin and cytochrome
EP1888106A4 (en) * 2005-05-20 2009-01-14 Univ Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005018662A1 (en) * 2003-08-15 2005-03-03 Board Of Trustees Of The University Of Illinois Use of polypeptides of the cupredoxin family in cancer therapy
WO2006088508A2 (en) * 2004-10-07 2006-08-24 Ananda Chakrabarty Cupredoxin derived transport agents and methods of use thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE GENESEQ [online] DERWENT PUBLICATIONS LTD., LONDON, GB; 23 June 2004 (2004-06-23), XU R. ET AL: "Azurin as bacterial protein with wide spectrum antitumor function and its use and medical composition", XP002499408, retrieved from EBI Database accession no. ADV69505 *
DATABASE UNIPROT [online] 21 July 1986 (1986-07-21), "RecName: Full=Azurin; Flags: Precursor;", retrieved from EBI accession no. UNIPROT:P00282 Database accession no. P00282 *
YAMADA TOHRU; FIALHO ARSENIO M; PUNJ VASU; BRATESCU LAURA; DAS GUPTA TAPAS K; CHAKRABARTY ANANDA M: "Internalization of bacterial redox protein azurin in mammalian cells: entry domain and specificity", CELLULAR MICROBIOLOGY, vol. 7, no. 10, 5 July 2005 (2005-07-05) - 25 October 2005 (2005-10-25), pages 1418 - 1431, XP002499203 *

Also Published As

Publication number Publication date
MX2008000993A (en) 2008-03-19
JP2009502797A (en) 2009-01-29
WO2007024368A2 (en) 2007-03-01
BRPI0615555A2 (en) 2009-07-14
WO2007024368A3 (en) 2007-10-11
EP1904081A2 (en) 2008-04-02
IL188691A0 (en) 2008-08-07
NO20080829L (en) 2008-04-02
AU2006284490A8 (en) 2008-02-28
CA2615560A1 (en) 2007-03-01
AU2006284490A1 (en) 2007-03-01
KR20080034905A (en) 2008-04-22

Similar Documents

Publication Publication Date Title
GB2469243B (en) Improvements in or relating to ablutionary installations
PH12008501163B1 (en) Shading composition
EP2086318A4 (en) Neuroprotective compositions and methods
EP2101731A4 (en) Endoxifen methods and compositions
EP2088865A4 (en) Guggulphospholipid methods and compositions
GB0617171D0 (en) Novel compositions and methods
GB0622399D0 (en) Novel compositions and uses thereof
ZA201001305B (en) Pyrone analog compositions and methods
GB0519717D0 (en) Improvements in or relating to devices
GB2425531B (en) Cement compositions with aplite
GB0520931D0 (en) Improvements in or relating to compositions
ZA200802220B (en) Improvements in or relating to compositions
EP1998753A4 (en) High-deposition compositions and uses thereof
ZA200800503B (en) Compositions and methods to control angiogenesis with cupredoxins
IL188691A0 (en) Compositions and methods to control angiogenesis with cupredoxins
GB0622400D0 (en) Novel compositions and uses thereof
GB0600336D0 (en) Composition and uses thereof
EP2010141A4 (en) High-deposition compositions and uses thereof
EP1889173A4 (en) Subscribing to content
GB0500224D0 (en) Improvements in or relating to ablutionary installations
GB0614252D0 (en) Improvements to building elements
GB0504185D0 (en) Improved glazing composition and uses thereof
GB0500847D0 (en) Claims to be made
GB0517718D0 (en) Further improvement to brikmat
GB0615912D0 (en) Herbal composition

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080117

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

RAX Requested extension states of the european patent have changed

Extension state: RS

Extension state: MK

Extension state: HR

Extension state: BA

Extension state: AL

A4 Supplementary search report drawn up and despatched

Effective date: 20081105

17Q First examination report despatched

Effective date: 20090219

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20121009